Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795. (Q33871694)

29 July 2017

title

Neuroprotection by metabotropic glutamate receptor glutamate receptor agonists: LY354740, LY379268 and LY389795. (English)

1 reference

29 July 2017

A E Kingston

1

1 reference

29 July 2017

M J O'Neill

2

1 reference

29 July 2017

A Lam

3

1 reference

29 July 2017

K R Bales

4

1 reference

29 July 2017

J A Monn

5

1 reference

29 July 2017

D D Schoepp

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

European Journal of Pharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

377

1 reference

29 July 2017

issue

2-3

1 reference

29 July 2017

page(s)

155-165

1 reference

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Facilitatory coupling between a glutamate metabotropic receptor and dihydropyridine-sensitive calcium channels in cultured cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Activation of metabotropic receptors has a neuroprotective effect in a rodent model of focal ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Ionic dependence of glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Glutamate neurotoxicity and diseases of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Pharmacology and functions of metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Intra-ischemic extracellular release of dopamine and glutamate is associated with striatal vulnerability to ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

A quantitative assay for fragmented DNA in apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Staurosporine-induced neuronal apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Adenosine A1 receptor activation preferentially protects cultured cerebellar neurons versus astrocytes against hypoxia-induced death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Activation of the metabotropic glutamate receptor is neuroprotective during nitric oxide toxicity in primary hippocampal neurons of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Cyclothiazide treatment unmasks AMPA excitotoxicity in rat primary hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

The metabotropic excitatory amino acid receptor agonist 1S,3R-ACPD selectively potentiates N-methyl-D-aspartate-induced brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxioly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Metabotropic glutamate receptors in brain function and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Kainate induces apoptosis in neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Metabotropic glutamate receptor (mGluR)-mediated potentiation of cyclic AMP responses does not require phosphoinositide hydrolysis: mediation by a group II-like mGluR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900397-0

10.1016/S0014-2999(99)00397-0

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference